Table 1. Basic clinical parameters for HCC patients.
| Clinical parameters | Value |
| Total number of patients | 97 |
| Gender-male, n (%) | 62 (63.9%) |
| Age (years) | 65.8±9.8 |
| HBsAg-positive, n (%) | 49 (50.5%) |
| Anti-HCV-positive, n (%) | 42 (43.3%) |
| Alcoholism, n (%) | 19 (19.6%) |
| Cirrhosis, n (%) | 87 (89.7%) |
| RFAa, n (%) | 79 (81.4%) |
| Microvascular invasionb, n (%) | 5 (5.2%) |
| Ascites, n (%) | 11 (11.3%) |
| Cytology grading <3, n (%) | 67 (69.1%) |
| Solitary tumor, n (%) | 73 (75.3%) |
| Tumor size (diameter, cm) | 3.14±2.0 |
| Alpha-fetoprotein (ng/mL) | 53.6±104.2 |
| Albumin (g/dL) | 3.7±0.5 |
| Bilirubin (mg/dL) | 1.1±0.7 |
| Prothrombin time (seconds) | 12.8±1.5 |
| Creatinine (mg/dL) | 1.4±1.8 |
| AST (U/L) | 58.0±48.9 |
| ALT (U/L) | 49.1±43.5 |
a
Other patients had tumors removed surgically.
b
Post-surgery specimens.